Sumitomo Chemical invests in nucleic acid drug company Bonac

The investment is 4 billion Yen and expands Sumitomo’s share in the company to 19,55 %. Bonac is a specialist for modified RNA synthesis (Bonac nucleic acids) which exhibit good stability and may lead to novel mucleic acid drugs. Bonac news release, September 26,...

Asahi Kasei obtains license for bone regenerative cell therapy

The license, exclusive for Japan, Korea, China and Taiwan, comes from Belgium’s Bone Therapeutics, Inc., and is directed to the cellular drug PREOB. PREOB is an autologous cell product produced from the patient’s bone marrow. Osteoblasts contained in PREOB...

Solarenergie für Sensoren und Displays im T-Shirt

Ein Team des RIKEN und der Universität Tokio haben ultradünne organische Solarzellen entwickelt, die sich dehnen und waschen lassen. Eine nur 3 µ dicke Siegelfolie besteht aus einem Thiazolothiazol-/Naphthobisthiadiazol-Halbleitercopolymer, der beidseitig in Parylen...